Case Report
Pyoderma gangrenosum: A single-center case series study of 32 cases
Downloads
- Download
Copyright
The authors shall retain the copyright of their work but allow the Publisher to publish, copy, distribute, and convey the work.
License
Trends in Immunotherapy (TI) publishes accepted manuscripts under Creative Commons Attribution 4.0 International (CC BY 4.0). Authors who submit their papers for publication by TI agree to have the CC BY 4.0 license applied to their work, and that anyone is allowed to reuse the article or part of it free of charge for any purpose, including commercial use. As long as the author and original source are properly cited, anyone may copy, redistribute, reuse, and transform the content.
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis with multiple different clinical presentations and associated comorbidities. It often presents as ulcerated lesions with a violet/erythematous border and an irregular undercut margin. In this largest single-centre case series study in Antalya-Turkey, we reviewed 32 PG patients diagnosed consecutively within the last 5-year period. Consistent with the literature, PG morphologically often presented with the ulcerative clinic (90.6%), and inflammatory bowel disease (15.6%) was the most common etiologic factor. In our study, female gender predominance (78.2%), lower extremity localization (93.7%), and the rate of multiple ulcers at diagnosis (90.6%) were more prominent than in the literature. Unlike the literature, oral mucosa involvement and syndromic form (both, 6.2%) of the disease were detected more frequently. Our results indicate that PG patients may show differences according to geographical and ethnic differences and/or characteristics of the healthcare institution.
Keywords:
pyoderma gangrenosum case series neutrophilic dermatosisReferences
- Maverakis E, Marzano AV, Le ST, et al. Pyoderma gangrenosum. Nature Reviews Disease Primers 2020; 6(1): 81. doi: 10.1038/s41572-020-0213-x
- Marzano AV, Trevisan V, Galloni C, Alessi E. Fatal bullous pyoderma gangrenosum in a patient with Klinefelter’s syndrome. Acta Dermato-Venereologica 2008; 88(2): 158–159. doi: 10.2340/00015555-0346
- Kridin K, Cohen AD, Amber KT. Underlying systemic diseases in pyoderma gangrenosum: A systematic review and meta-analysis. American Journal of Clinical Dermatology 2018; 19(4): 479–487. doi: 10.1007/s40257-018-0356-7
- Serdar Aşiran Z, Yaşar Ş, Güneş P. Pyoderma gangrenosum: Retrospective evaluation of 20 cases. Turkderm-Turk Arch Dermatol Venereol 2011; 45(2): 83–87. doi: 10.4274/turkderm.45.19
- Duman N, Ersoy Evans S. Pyoderma gangrenosum: A retrospective study of 25 cases and review of literature findings. Turkiye Klinikleri Journal of Dermatology 2013; 23(3): 77–83.
- Adisen E, Erduran F, Gürer MA. Pyoderma gangrenosum: A report of 27 patients. The International Journal of Lower Extremity Wounds 2016; 15(2): 148–154. doi: 10.1177/1534734616639172
- Binus AM, Qureshi AA, Li VW, Winterfield LS. Pyoderma gangrenosum: A retrospective review of patient characteristics, comorbidities and therapy in 103 patients. British Journal of Dermatology 2011; 165(6): 1244–1250. doi: 10.1111/j.1365-2133.2011.10565.x
- Kim YJ, Lee KH, Won CH, et al. Clinicopathological features and prognosis of pyoderma gangrenosum in Korea: A single-centre, retrospective, 20-year observational study. Indian Journal of Dermatology, Venereology and Leprology 2023; 89(1): 25–34. doi: 10.25259/IJDVL_968_20